Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.
Schiffman KS, Bensinger WI, Appelbaum FR, Rowley S, Lilleby K, Clift RA, Weaver CH, Demirer T, Sanders JE, Petersdorf S, Gooley T, Weiden P, Zuckerman N, Montgomery P, Maziarz R, Klarnet JP, Rivkin S, Trueblood K, Storb R, Holmberg L, Buckner CD. Schiffman KS, et al. Among authors: maziarz r. Bone Marrow Transplant. 1996 Jun;17(6):943-50. Bone Marrow Transplant. 1996. PMID: 8807098 Clinical Trial.
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma.
Bensinger WI, Rowley SD, Demirer T, Lilleby K, Schiffman K, Clift RA, Appelbaum FR, Fefer A, Barnett T, Storb R, Chauncey T, Maziarz RT, Klarnet J, McSweeney P, Holmberg L, Maloney DG, Weaver CH, Buckner CD. Bensinger WI, et al. Among authors: maziarz rt. J Clin Oncol. 1996 May;14(5):1447-56. doi: 10.1200/JCO.1996.14.5.1447. J Clin Oncol. 1996. PMID: 8622058 Clinical Trial.
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
Brunvand MW, Bensinger WI, Soll E, Weaver CH, Rowley SD, Appelbaum FR, Lilleby K, Clift RA, Gooley TA, Press OW, Fefer A, Storb R, Sanders JE, Martin PL, Chauncey T, Maziarz RT, Zuckerman N, Montgomery P, Dorn R, Weiden PL, Demirer T, Holmberg LA, Schiffman K, McSweeney PA, Buckner CD, et al. Brunvand MW, et al. Among authors: maziarz rt. Bone Marrow Transplant. 1996 Jul;18(1):131-41. Bone Marrow Transplant. 1996. PMID: 8832006 Clinical Trial.
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.
Bensinger WI, Schiffman KS, Holmberg L, Appelbaum FR, Maziarz R, Montgomery P, Ellis E, Rivkin S, Weiden P, Lilleby K, Rowley S, Petersdorf S, Klarnet JP, Nichols W, Hertler A, McCroskey R, Weaver CH, Buckner CD. Bensinger WI, et al. Among authors: maziarz r. Bone Marrow Transplant. 1997 Jun;19(12):1183-9. doi: 10.1038/sj.bmt.1700820. Bone Marrow Transplant. 1997. PMID: 9208111
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
Schiffman K, Buckner CD, Maziarz R, Maloney DG, Appelbaum FR, Press O, Gooley T, Holmberg L, Lilleby K, Clift R, Zuckerman N, Klarnet J, Weaver C, Chauncey T, Bensinger WI. Schiffman K, et al. Among authors: maziarz r. Biol Blood Marrow Transplant. 1997 Nov;3(5):261-6. Biol Blood Marrow Transplant. 1997. PMID: 9450921
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.
Holmberg LA, Demirer T, Rowley S, Buckner CD, Goodman G, Maziarz R, Klarnet J, Zuckerman N, Harrer G, McCloskey R, Gersh R, Goldberg R, Nichols W, Jacobs A, Weiden P, Montgomery P, Rivkin S, Appelbaum FR, Bensinger WI. Holmberg LA, et al. Among authors: maziarz r. Bone Marrow Transplant. 1998 Oct;22(7):651-9. doi: 10.1038/sj.bmt.1701398. Bone Marrow Transplant. 1998. PMID: 9818692
A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
List AF, Maziarz R, Stiff P, Jansen J, Liesveld J, Andrews F, Schuster M, Wolff S, Litzow M, Karanes C, Dahlberg S, Kirkhart B, Bianco JA, Singer JW. List AF, et al. Among authors: maziarz r. Bone Marrow Transplant. 2000 Feb;25(3):283-91. doi: 10.1038/sj.bmt.1702114. Bone Marrow Transplant. 2000. PMID: 10673700 Clinical Trial.
Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial.
Yanovich S, Mitsky P, Cornetta K, Maziarz RT, Rosenfeld C, Krause DS, Lotz JP, Bitran JD, Williams S, Preti R, Somlo G, Burtness B, Mills B. Yanovich S, et al. Among authors: maziarz rt. Bone Marrow Transplant. 2000 Jun;25(11):1165-74. doi: 10.1038/sj.bmt.1702415. Bone Marrow Transplant. 2000. PMID: 10849529 Clinical Trial.
326 results